Multiple Sclerosis (MS) Clinical Trials

Find Multiple Sclerosis (MS) Clinical Trials Near You

Relationship Between Spinal Alignment, Spinal Mobility, and Balance in Patients With Multiple Sclerosis

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system characterized by demyelination and axonal degeneration. Neuromuscular impairments associated with MS, including muscle weakness, spasticity, fatigue, and proprioceptive deficits, may lead to alterations in spinal posture and reduced spinal mobility. These changes can negatively affect trunk control, balance, respiratory function, and functional independence. Although postural abnormalities and mobility limitations have been reported in individuals with MS, the relationship between spinal posture, spinal mobility, and balance remains insufficiently investigated. Therefore, this study aims to examine the associations between spinal posture, spinal mobility, and balance performance in individuals with multiple sclerosis. Improved understanding of these relationships may contribute to the development of targeted rehabilitation interventions aimed at enhancing postural control and functional outcomes in this population. This study further hypothesises that alterations in spinal posture and spinal mobility are associated with impaired balance performance in individuals with multiple sclerosis.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: t
View:

• Diagnosis of relapsing-remitting multiple sclerosis (RRMS)

• Aged between 18 and 65 years

• EDSS score between 0.5 and 4.5

• Standardized Mini-Mental State Examination score ≥24

Locations
Other Locations
Turkey
Ankara Yıldırım Beyazıt University
RECRUITING
Ankara
Time Frame
Start Date: 2026-02-01
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 30
Treatments
Multiple Sclerosis
Related Therapeutic Areas
Sponsors
Leads: Ankara Yildirim Beyazıt University

This content was sourced from clinicaltrials.gov